Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Using fungi
Patent
1998-02-04
2000-08-29
Richter, Johann
Chemistry: molecular biology and microbiology
Micro-organism, tissue cell culture or enzyme using process...
Using fungi
544360, 549267, 514450, A61K 3135, C07D31178, C07D32110
Patent
active
061107166
ABSTRACT:
Natural products such as certain chaetochromins are described. These compounds are useful in the inhibition of HIV integrase, the prevention or treatment of infection by HIV and the treatment of AIDS, either as compounds, pharmaceutically acceptable salts, pharmaceutical composition ingredients, whether or not in combination with other antivirals, immunomodulators, antibiotics or vaccines. Methods of treating AIDS and methods of preventing or treating infection by HIV are also described.
REFERENCES:
Koyama et al., Further Characterization of Seven Bis(naphtho-y-pyrone) Congeners of Ustilaginoidins, Coloring Matters of Claviceps virens (Ustilaginoidea virens), Chem. Pharm. Bull. vol. 36(1) pp. 146-152 (1988).
Koyama et al., Database HCAPLUS, Chem. Pharm. Bull, vol. 35 (10), pp. 4049-4055 (1987), No. 1988:50979 (Abstract).
Kawai et al., Database HCAPLUS on STN, No. 1992:53265, vol. 33, pp. 31-35 (1991) (Abstract).
Koyama et al., Database HCAPLUS, Chem. Pharm. Bull., vol. 36(1), pp. 146-152 (1988), No. 1988:164483 (Abstract).
Kawai et al., Database HCAPLUS on STN, No. 1992:35988, vol. 33, pp. 25-29 (1991) (Abstract).
LaFemina et al., Antimicrobial Agents & Chemotherapy, vol. 39(2), pp. 320-324 (1995), "Inhibition of human immunodeficiency virus integrase by bis-catechols".
Cushman et al., J. Med. Chem., vol. 38 (1995), pp. 443-452, "Cosalane analogues with enhanced potencies as inhibitors of HIV-1 protease and integrase".
Mazumder et al., Biochemistry, vol. 34 (1995), pp. 15111-15122, "Effects of tyrphostins, protein kinase inhibitors, on human immunodeficiency virus type 1 integrase".
Mazumder et al., J. Med. Chem., vol. 39 (1996), pp. 2472-2481, "Antiretroviral agents as inhibitors of both human immunodeficiency virus type 1 integrase and protease".
Mazumder et al., Molecular Pharmacology, vol. 49 (1996), pp. 621-628, "Effects of nucleotide analogues on human immunodeficiency virus type 1 integrase".
Kusumoto et al., C.A. 120(19):238888s, "A comparative study on the inhibitory effects of flavonoids and alkaloids on reverse transcriptases of different retroviruses", Shoyakugaku Zasshi, 47(3), pp. 291-294, 1993. (Abstract).
Mazumder et al., AIDS Research and Human Retroviruses, vol. 11(1), pp. 115-125 (1995), "Inhibition of human immunodeficiency virus type 1 integrase by a hydrophobic cation . . . ".
Mazumder et al., Proc. Nat'l Acad. Sci. USA, vol. 91, pp. 5771-5775 (1994), "Inhibition of human immunodeficiency virus type 1 integrase by 3'-azido-3'-deoxythymidylate".
Carteau et al., Archives of Biochemistry & Biophysics, vol. 305(2), pp. 606-610 (1993), "Inhibitory effect of the polyanionic drug suramin on the in vitro HIV DNA integration reaction".
Fesen et al., Proc. Nat'l Acad. Sci. USA, vol. 90 (1993), pp. 2399-2403, "Inhibitors of human immunodeficiency virus integrase".
Farnet et al., Proc. Nat'l Acad. Sci. USA, vol. 93 (1996), pp. 9742-9747, "Differential inhibition of HIV-1 preintegration complexes and purified integrase protein by small molecules".
Lutzke et al., Proc. Nat'l Acad. Sci. USA, vol. 92 (1995), pp. 11456-11460, "Identification of a hexapeptide inhibitor of the human immunodeficiency virus integrase protein by using a combinatorial chemical library".
Ojwang et al., Antimicrobial Agents & Chemotherapy, vol. 39(11), pp. 2426-2435 (1995), "T30177, an oligonucleotide stabilized by an intramolecular guanosine octet, is a potent inhibitor . . . ".
Eich et al., J. Med. Chem., vol. 39 (1996), pp. 86-95, "(-)-Arctigenin as a lead structure for inhibitors of human immunodeficiency virus type-1 integrase".
Robinson, Jr., et al., Proc. Nat'l Acad. Sci. USA, vol. 93 (1996), pp. 6326-6331, "Inhibitors of HIV-1 replication that inhibit HIV integrase".
PRNewswire, Sep. 17, 1996, "Aronex reports results for lead anti-HIV integrase inhibitor compound".
Neamati et al., "Design and discovery of HIV-1 integrase inhibitors", DDT 2(11) (1997), pp. 487-498.
Hazuda et al., Nucleic Acids Research, vol. 22 (6), pp. 1121-1122 (1994), "A novel assay for the DNA strand-transfer reaction of HIV-1 integrase".
Burke et al., J. Med. Chem., vol. 38 (1995), pp. 4171-4178, "Hydroxylated aromatic inhibitors of HIV-1 integrase".
Hazuda et al., J. of Virology, vol. 71(1), pp. 807-811 (1997), "Equivalent inhibition of half-site and full-site retroviral strand transfer reactions by structurally diverse compounds".
Fesen et al., Biochemical Pharma., vol. 48(3), pp. 595-608 (1994), "Inhibition of HIV-1 integrase by flavones, caffeic acid phenethyl ester (cape) and related compounds".
Koyama et al., Chem. Pharm. Bull., 36(1), 146-152. 1988.
Mori et al., Mycotoxin Research, vol. 9, 85-93, 1993.
Koyama et al., Tennen Yuki Kagobutsu Toronkai Koen Yoshishu, 29, 713-720, 1987.
Lingham Russell B.
Shafiee Ali
Silverman Keith C.
Singh Sheo Bux
Teran Ana M.
Fitch Catherine D.
Merck & Co. , Inc.
Richter Johann
Solola Taofiq A.
Walton Kenneth R.
LandOfFree
HIV integrase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with HIV integrase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and HIV integrase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1248733